Science

This can be a short description about this vertical and all the great links contained therein.

R&D Strategy

Evidence

Pipeline

Clinical Trials

Article originally published February 2026 […]

Learn More ›

Products

This can be a short description about this vertical and all the great links contained therein.

Sepsis ImmunoScore®

First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities

5th World Sepsis Congress  |  […]

Learn More ›

Resources

This can be a short description about this vertical and all the great links contained therein.

Resource Library

Events

Sepsis ImmunoScore® demonstrates stronger predictive […]

Learn More ›

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore® demonstrates stronger predictive […]

Learn More ›

About

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Mission, Vision, Values

Careers

Leadership

Awards

AI in Chicago  |  Episode […]

Learn More ›

AI in Chicago: Breaking Through Healthcare’s Most Challenging Frontier

AI in Chicago  |  Episode 8  |  Breaking Through Healthcare’s Most Challenging Frontier

Interview originally published on AI in Chicago September 24, 2025

Listen in as Khullani Abdullahi, JD, founder of Techne AI & BoardSight AI, interviews Prenosis CEO and co-founder, Bobby Reddy, Jr., PhD.

Bobby discusses his decade-long journey to develop the first FDA-authorized AI tool for sepsis diagnostics. The conversation reveals profound insights about innovation in acute care, the realities of building healthcare AI, and what it takes to solve truly complex problems in healthcare’s most challenging frontier.

Listen to the interview >